232 related articles for article (PubMed ID: 27467053)
1. An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
Zhu B; Mukherjee A; Machiela MJ; Song L; Hua X; Shi J; Garcia-Closas M; Chanock SJ; Chatterjee N
Br J Cancer; 2016 Sep; 115(6):752-60. PubMed ID: 27467053
[TBL] [Abstract][Full Text] [Related]
2. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs.
Guan YP; Yang XX; Yao GY; Qiu F; Chen J; Chen LJ; Ye CS; Li M
Asian Pac J Cancer Prev; 2014; 15(1):85-91. PubMed ID: 24528085
[TBL] [Abstract][Full Text] [Related]
4. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract][Full Text] [Related]
5. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.
Wang S; Pitt JJ; Zheng Y; Yoshimatsu TF; Gao G; Sanni A; Oluwasola O; Ajani M; Fitzgerald D; Odetunde A; Khramtsova G; Hurley I; Popoola A; Falusi A; Ogundiran T; Obafunwa J; Ojengbede O; Ibrahim N; Barretina J; White KP; Huo D; Olopade OI
Int J Cancer; 2019 Dec; 145(12):3321-3333. PubMed ID: 31173346
[TBL] [Abstract][Full Text] [Related]
6. An admixture scan in 1,484 African American women with breast cancer.
Fejerman L; Haiman CA; Reich D; Tandon A; Deo RC; John EM; Ingles SA; Ambrosone CB; Bovbjerg DH; Jandorf LH; Davis W; Ciupak G; Whittemore AS; Press MF; Ursin G; Bernstein L; Huntsman S; Henderson BE; Ziv E; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3110-7. PubMed ID: 19843668
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutational profiles and germline polygenic risk scores in human cancer.
Liu Y; Gusev A; Heng YJ; Alexandrov LB; Kraft P
Genome Med; 2022 Feb; 14(1):14. PubMed ID: 35144655
[TBL] [Abstract][Full Text] [Related]
8. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Mulligan AM; Couch FJ; Barrowdale D; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Robson M; Sherman M; Spurdle AB; Wappenschmidt B; Lee A; McGuffog L; Healey S; Sinilnikova OM; Janavicius R; Hansen Tv; Nielsen FC; Ejlertsen B; Osorio A; Muñoz-Repeto I; Durán M; Godino J; Pertesi M; Benítez J; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Bonanni B; Viel A; Pasini B; Papi L; Ottini L; Savarese A; Bernard L; Radice P; Hamann U; Verheus M; Meijers-Heijboer HE; Wijnen J; Gómez García EB; Nelen MR; Kets CM; Seynaeve C; Tilanus-Linthorst MM; van der Luijt RB; van Os T; Rookus M; Frost D; Jones JL; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Cook J; Donaldson A; Dorkins H; Gregory H; Eason J; Houghton C; Barwell J; Side LE; McCann E; Murray A; Peock S; Godwin AK; Schmutzler RK; Rhiem K; Engel C; Meindl A; Ruehl I; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Kast K; Preisler-Adams S; Varon-Mateeva R; Schoenbuchner I; Fiebig B; Heinritz W; Schäfer D; Gevensleben H; Caux-Moncoutier V; Fassy-Colcombet M; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Hardouin A; Berthet P; Muller D; Fricker JP; Mortemousque I; Pujol P; Coupier I; Lebrun M; Kientz C; Longy M; Sevenet N; Stoppa-Lyonnet D; Isaacs C; Caldes T; de la Hoya M; Heikkinen T; Aittomäki K; Blanco I; Lazaro C; Barkardottir RB; Soucy P; Dumont M; Simard J; Montagna M; Tognazzo S; D'Andrea E; Fox S; Yan M; Rebbeck T; Olopade O; Weitzel JN; Lynch HT; Ganz PA; Tomlinson GE; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Szabo C; Offit K; Sakr R; Gaudet M; Bhatia J; Kauff N; Singer CF; Tea MK; Gschwantler-Kaulich D; Fink-Retter A; Mai PL; Greene MH; Imyanitov E; O'Malley FP; Ozcelik H; Glendon G; Toland AE; Gerdes AM; Thomassen M; Kruse TA; Jensen UB; Skytte AB; Caligo MA; Soller M; Henriksson K; Wachenfeldt vA; Arver B; Stenmark-Askmalm M; Karlsson P; Ding YC; Neuhausen SL; Beattie M; Pharoah PD; Moysich KB; Nathanson KL; Karlan BY; Gross J; John EM; Daly MB; Buys SM; Southey MC; Hopper JL; Terry MB; Chung W; Miron AF; Goldgar D; Chenevix-Trench G; Easton DF; Andrulis IL; Antoniou AC; ; ; ; ; ; ; ;
Breast Cancer Res; 2011; 13(6):R110. PubMed ID: 22053997
[TBL] [Abstract][Full Text] [Related]
9. Impact of NR5A2 and RYR2 3'UTR polymorphisms on the risk of breast cancer in a Chinese Han population.
Wei Y; Wang X; Zhang Z; Zhao C; Chang Y; Bian Z; Zhao X
Breast Cancer Res Treat; 2020 Aug; 183(1):1-8. PubMed ID: 32572717
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
[TBL] [Abstract][Full Text] [Related]
11. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
[TBL] [Abstract][Full Text] [Related]
12. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
[TBL] [Abstract][Full Text] [Related]
13. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.
Warren H; Dudbridge F; Fletcher O; Orr N; Johnson N; Hopper JL; Apicella C; Southey MC; Mahmoodi M; Schmidt MK; Broeks A; Cornelissen S; Braaf LM; Muir KR; Lophatananon A; Chaiwerawattana A; Wiangnon S; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Sawyer EJ; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Guénel P; Truong T; Laurent-Puig P; Mulot C; Bojesen SE; Nielsen SF; Flyger H; Nordestgaard BG; Milne RL; Benítez J; Arias-Pérez JI; Zamora MP; Anton-Culver H; Ziogas A; Bernstein L; Dur CC; Brenner H; Müller H; Arndt V; Langheinz A; Meindl A; Golatta M; Bartram CR; Schmutzler RK; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Wang-Gohrke S; Eilber U; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov Y; Bermisheva M; Prokofyeva D; Zinnatullina G; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Hartikainen JM; Kataja V; Chenevix-Trench G; Beesley J; Chen X; ; ; Lambrechts D; Smeets A; Paridaens R; Weltens C; Flesch-Janys D; Buck K; Behrens S; Peterlongo P; Bernard L; Manoukian S; Radice P; Couch FJ; Vachon C; Wang X; Olson J; Giles G; Baglietto L; McLean CA; Severi G; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Mulligan AM; Weerasooriya N; Devilee P; Tollenaar RA; Martens JW; Seynaeve CM; Hooning MJ; Hollestelle A; Jager A; Tilanus-Linthorst MM; Hall P; Czene K; Liu J; Li J; Cox A; Cross SS; Brock IW; Reed MW; Pharoah P; Blows FM; Dunning AM; Ghoussaini M; Ashworth A; Swerdlow A; Jones M; Schoemaker M; Easton DF; Humphreys M; Wang Q; Peto J; dos-Santos-Silva I
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1783-91. PubMed ID: 22859399
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel genetic markers of breast cancer survival.
Guo Q; Schmidt MK; Kraft P; Canisius S; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Kar S; Beesley J; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Couch FJ; Olson JE; Vachon C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Broeks A; Hogervorst FB; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cox A; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Dieffenbach AK; Arndt V; Holleczek B; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Bonanni B; Mariani P; Fasching PA; Beckmann MW; Hein A; Ekici AB; Chenevix-Trench G; Balleine R; ; Phillips KA; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; Evans DG; Abraham JE; Earl HM; Hiller L; Dunn JA; Bowden S; Berg C; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson SE; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; García-Closas M; Hall P; Easton DF; Eccles DM; Rahman N; Nevanlinna H; Pharoah PD
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25890600
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
[TBL] [Abstract][Full Text] [Related]
16. Hormone-related pathways and risk of breast cancer subtypes in African American women.
Haddad SA; Lunetta KL; Ruiz-Narváez EA; Bensen JT; Hong CC; Sucheston-Campbell LE; Yao S; Bandera EV; Rosenberg L; Haiman CA; Troester MA; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2015 Nov; 154(1):145-54. PubMed ID: 26458823
[TBL] [Abstract][Full Text] [Related]
17. 11q13 is a susceptibility locus for hormone receptor positive breast cancer.
Lambrechts D; Truong T; Justenhoven C; Humphreys MK; Wang J; Hopper JL; Dite GS; Apicella C; Southey MC; Schmidt MK; Broeks A; Cornelissen S; van Hien R; Sawyer E; Tomlinson I; Kerin M; Miller N; Milne RL; Zamora MP; Pérez JI; Benítez J; Hamann U; Ko YD; Brüning T; ; Chang-Claude J; Eilber U; Hein R; Nickels S; Flesch-Janys D; Wang-Gohrke S; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Chenevix-Trench G; Beesley J; Chen X; ; ; Menegaux F; Cordina-Duverger E; Shen CY; Yu JC; Wu PE; Hou MF; Andrulis IL; Selander T; Glendon G; Mulligan AM; Anton-Culver H; Ziogas A; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Jones M; Orr N; Ashworth A; Swerdlow A; Severi G; Baglietto L; Giles G; Southey M; Marmé F; Schneeweiss A; Sohn C; Burwinkel B; Yesilyurt BT; Neven P; Paridaens R; Wildiers H; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schott S; Bartram CR; Schmutzler RK; Cox A; Brock IW; Elliott G; Cross SS; Fasching PA; Schulz-Wendtland R; Ekici AB; Beckmann MW; Fletcher O; Johnson N; Silva Idos S; Peto J; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Dörk T; Schürmann P; Bremer M; Hillemanns P; Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Khusnutdinova E; Bermisheva M; Prokofieva D; Gancev S; Jakubowska A; Lubinski J; Jaworska K; Durda K; Nordestgaard BG; Bojesen SE; Lanng C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Radice P; Peterlongo P; Manoukian S; Bernard L; Couch FJ; Olson JE; Wang X; Fredericksen Z; Alnaes GG; Kristensen V; Børresen-Dale AL; Devilee P; Tollenaar RA; Seynaeve CM; Hooning MJ; García-Closas M; Chanock SJ; Lissowska J; Sherman ME; Hall P; Liu J; Czene K; Kang D; Yoo KY; Noh DY; Lindblom A; Margolin S; Dunning AM; Pharoah PD; Easton DF; Guénel P; Brauch H
Hum Mutat; 2012 Jul; 33(7):1123-32. PubMed ID: 22461340
[TBL] [Abstract][Full Text] [Related]
18. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.
Roberts MR; Sucheston-Campbell LE; Zirpoli GR; Higgins M; Freudenheim JL; Bandera EV; Ambrosone CB; Yao S
Mol Carcinog; 2017 Mar; 56(3):1000-1009. PubMed ID: 27597141
[TBL] [Abstract][Full Text] [Related]
20. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
Azzato EM; Tyrer J; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Arias JI; Menéndez P; Benítez J; Chang-Claude J; Hein R; Wang-Gohrke S; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kosma VM; Kataja V; ; Beesley J; Chen X; Chenevix-Trench G; Couch FJ; Olson JE; Fredericksen ZS; Wang X; Giles GG; Severi G; Baglietto L; Southey MC; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Lissowska J; Sherman ME; Bolton KL; Hall P; Czene K; Cox A; Brock IW; Elliott GC; Reed MW; Greenberg D; Anton-Culver H; Ziogas A; Humphreys M; Easton DF; Caporaso NE; Pharoah PD
J Natl Cancer Inst; 2010 May; 102(9):650-62. PubMed ID: 20308648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
